Cite

HARVARD Citation

    Natsagdorj, A. et al. (2019). CCL2 induces resistance to the antiproliferative effect of cabazitaxel in prostate cancer cells. Cancer science. 110 (1), pp. 279-288. [Online]. 
  
Back to record